Teva Pharmaceutical Inds
ISIN US8816242098
|WKN 883035
Overview
Quote
Trade with your broker
Description
Teva Pharmaceutical Industries Ltd. beschäftigt sich mit der Entwicklung, der Produktion und dem Verkauf von Medikamenten. Das Unternehmen ist in den folgenden geografischen Segmenten tätig: Vereinigte Staaten, Europa und Internationale Märkte. Das US-Segment konzentriert sich auf den therapeutischen Bereich des Zentralen Nervensystems (ZNS) und ist im Vertrieb von Generika, Biosimilars, Medikamenten und rezeptfreien Arzneimitteln (OTC) des Unternehmens und von Drittherstellern an unabhängige Einzelhandelsapotheken, Apothekenketten, Krankenhäuser und Arztpraxen in den Vereinigten Staaten tätig. Das Segment Europa bietet sein OTC-Portfolio einschließlich der Marken SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max und FLEGAMINA in der Europäischen Union, dem Vereinigten Königreich und bestimmten anderen europäischen Ländern an. Das Segment Internationale Märkte bietet seine Produkte in Ländern wie Kanada, Israel, Russland, Lateinamerika und Japan an. Das Unternehmen wurde 1901 gegründet und hat seinen Hauptsitz in Tel Aviv, Israel.
Gesundheitswesen Biopharmazeutische Produkte Andere Biopharmazeutika Israel
Financials
Key metrics
| Market capitalisation, EUR | 13.619,32 Mio. |
| EPS, EUR | -1,34 |
| P/B ratio | 2,84 |
| P/E ratio | - |
| Dividend yield | 0,00% |
Cuenta de resultados (2024)
| Revenue, EUR | 15.263,08 Mio. |
| Net income, EUR | -1.515,21 Mio. |
| Profit margin | -9,93% |
¿Qué ETF contiene Teva Pharmaceutical Inds?
Hay 88 ETF que contienen Teva Pharmaceutical Inds. Todos estos ETF están listados en la siguiente tabla. El ETF con la mayor ponderación de Teva Pharmaceutical Inds es el Harbor Health Care UCITS ETF Accumulating.
Savings plan offers
Aquí encontrarás información sobre la disponibilidad del plan de inversión para esta acción. Puedes usar la tabla para comparar las ofertas de planes de inversión ofertados para la cantidad de ahorro seleccionada.
Source: justETF Research; As of 4/2025; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
— The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
Performance
Returns overview
| YTD | -43.81% |
| 1 month | -19.63% |
| 3 months | -43.42% |
| 6 months | -27.58% |
| 1 year | -3.21% |
| 3 years | +27.70% |
| 5 years | +31.16% |
| Since inception (MAX) | -76.53% |
| 2024 | +130.93% |
| 2023 | +7.26% |
| 2022 | +16.51% |
| 2021 | -4.49% |
Monthly returns in a heat map
Risk
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risk overview
| Volatility 1 year | 46.40% |
| Volatility 3 years | 43.30% |
| Volatility 5 years | 42.43% |
| Return per risk 1 year | -0.07 |
| Return per risk 3 years | 0.20 |
| Return per risk 5 years | 0.13 |
| Maximum drawdown 1 year | -47.37% |
| Maximum drawdown 3 years | -47.37% |
| Maximum drawdown 5 years | -47.37% |
| Maximum drawdown since inception | -91.56% |
Rolling 1 year volatility
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
